Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer (2022) Kolben T, Müller L, Meister S, Keilmann L, Buschmann C, Trillsch F, Burges A, et al. Journal article The OUTREACH study: oncologists of German university hospitals in rotation on a palliative care unit-evaluation of attitude and competence in palliative care and hospice (2022) Biersching T, Schweda A, Oechsle K, Nauck F, Rosenbruch J, Schuler U, Hense J, et al. Journal article Quality assurance and improvement in oncology using guideline-derived quality indicators - results of gynaecological cancer centres certified by the German cancer society (DKG) (2022) Griesshammer E, Wesselmann S, Beckmann M, Dannecker C, Wagner U, Sibert NT, Armbrust R, Sehouli J Journal article Characteristics and outcome of patients with small bowel adenocarcinoma (SBA) (2022) Teufel A, Meindl-Beinker NM, Hosel P, Gerken M, Roig A, Ebert MP, Herr W, et al. Journal article R-CHOP intensification with mid-cycle methotrexate and consolidating AraC/TT with BCNU/aHSCT in primary aggressive lymphoma with CNS involvement (2022) Steinhardt MJ, Krummenast FC, Rosenwald A, Gerhard-Hartmann E, Heidemeier A, Einsele H, Topp MS, Duell J Journal article Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry (2022) Hanoun M, Ruhnke L, Kramer M, Hanoun C, Schaefer-Eckart K, Steffen B, Sauer T, et al. Journal article Mismatch repair deficiency, chemotherapy and survival for resectable gastric cancer: an observational study from the German staR cohort and a meta-analysis (2022) Stolze T, Franke S, Haybaeck J, Moehler M, Grimminger PP, Lang H, Roth W, et al. Journal article Assessment of sorafenib induced changes in tumor perfusion of uveal melanoma metastases with dynamic contrast-enhanced ultrasound (DCE-US) (2021) Wildner D, Heinzerling L, Scheulen ME, Kämpgen E, Schuler G, Strobel D, Janka RM, et al. Journal article Elotuzumab, pomalidomide, and dexamethasone is a very well tolerated regimen associated with durable remission even in very advanced myeloma: a retrospective study from two academic centers (2021) Hose D, Schreder M, Hefner J, Bittrich M, Danhof S, Strifler S, Krauth MT, et al. Journal article Inflammatory markers in autoimmunity induced by checkpoint inhibitors (2021) Husain B, Kirchberger M, Erdmann M, Schüpferling S, Abolhassani AR, Fröhlich W, Berking C, Heinzerling L Journal article